Article

Ki67 Assessment by qRT-PCR in OncotypeDx ® Breast Recurrent Score®: Low Correlation With IHC Assessment of ki67 and Prognostic Impact of ki67 RNA Level of Expression.

2021-05-21

Abstract excerpt

<h4>Background: </h4> Breast cancers expressing high levels of Ki67 are associated with poor outcomes. To provide individualized patient care, reliability of prognostic and predictive information deriving from Ki67 assessment is essential. Oncotype DX ® test was designed for ER+/HER2- early-stage breast cancers to help adjuvant chemotherapy decision by providing a Recurrent Score ® (RS ® ). RS ® measures the expre...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d9ff8da4-6654-5095-85b3-ce1ac24388f5
DOI: 10.21203/rs.3.rs-525965/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Ki67 Assessment by qRT-PCR in OncotypeDx ® Breast Recurrent Score®: Low Correlation With IHC Assessment of ki67 and Prognostic Impact of ki67 RNA Level of Expression.DOI 10.21203/rs.3.rs-525965/v1Read

Ki67 Assessment By qRT-PCR In OncotypeDx® Breast Recurrent Score®: Low Correlation With Immunohistochemistry Assessment of Ki67 And Prognostic Impact of Ki67 RNA Level of Expression.Semantic proximity Read

Evaluating the Association of Ki 67 with Oncotype DX Recurrence Score in Early-Stage ER Positive/HER2 Negative Breast CancerSemantic proximity Read

Favorable Locoregional Control in Clinically Node- Negative Hormone-receptor Positive Breast Cancer With Low 21-gene Recurrence Scores: a Single Institutional Study With 10-year Follow-upSemantic proximity Read

Associations Between the 21-Gene Oncotype DX Recurrence Score, Ki67, and Race in Early Breast Cancer: An Analysis of the National Cancer DatabaseSemantic proximity Read

The Role of Ki-67 in HR+/HER2- Breast Cancer: a Real-world Study of 956 PatientsSemantic proximity Read

Breast medical oncologists' use of standard prognostic factors to predict a 21-gene recurrence score.Semantic proximity Read

The 21-gene recurrence score in special histologic subtypes of breast cancer with favorable prognosis.Semantic proximity Read

Oncotype-DX recurrence score distribution in breast cancer patients with BRCA1/2 mutations.Semantic proximity Read

Ki-67 as a prognostic marker according to breast cancer molecular subtypeSemantic proximity Read

Clinical outcomes and Oncotype DX Breast Recurrence Score® in early-stage BRCA-associated hormone receptor-positive breast cancer.Semantic proximity Read

21-Gene recurrence score decreases receipt of chemotherapy in ER+ early-stage breast cancer: an analysis of the NCDB 2010-2013.Semantic proximity Read

The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence.Semantic proximity Read